CORONA, CA--(NewMediaWire - May 24, 2016) - Acology Inc
(OTC
PINK: ACOL) CEO Curt Fairbrother Announced Sales Increases
of 200% in 1st Quarter
Letter to Shareholders: From the Desk of Curt Fairbrother
CEO
Dear Acology Shareholders:
Since my last letter there have been several positive
developments that I want to share with you. Both retail and
wholesale orders for the first fiscal quarter of 2016 have
increased over 200% from this same period of time in 2015. This
continues a steady trend of increased new sales from each preceding
calendar month and assures the company will maintain its steady
growth through the remainder of the year. New orders have advanced
this month as well and we will begin the first deliveries of our
new product, custom lighters, which will complement our signature
product, The MedTainerâ„¢. This item will allow us to offer our
current wholesale and retail distributors an attractive, custom
designed product that can be sold separately or in tandem. Customer
retention continues to be a company strength. This is due to very
aggressive sales and marketing and a strong social media campaign,
which includes the launch of our new mobile app that can now be
downloaded on Apple and Android phones. (The MedTainer APK
Download) I'm pleased to tell you that this new marketing stratagem
is being quickly adopted by many new customers as well as our
establishment.
On the hospice and palliative care side of our business I am
very pleased to report that our presentations to the Philippine
Government and associated health agencies, hospitals and
pharmaceutical companies have generated great interest in our
products and I am confident that business will commence overseas
very soon. In light of the fact that the Philippine Government has
declared universal hospice and palliative care for all of its
citizens the use of The MedTainer works perfectly. A device to help
patients to easily ingest generic medications that are less
expensive is seen by Philippine Health Agencies as a measure that
will save millions of dollars in the future.
We are also now beginning use The MedTainer here in the US as a
way that transitional care patients, or patients who are being
treated in private homes, can establish an easy method to comply
with their physician's medication orders. Our first large-scale
clinical model will soon be making its debut, changing the paradigm
of how hospice and palliative care patients can be made more
comfortable easily and safely.
We are looking forward with great confidence to the remainder of
2016 and far beyond. Thank you for your continued support.
Sincerely,
Curt Fairbrother, CEO
Acology Inc. / D&C Distributors, LLC
This press release includes statements that are covered by the
Private Securities Litigation Reform Act of 1995. Because such
statements deal with future events they are subject to risks and
uncertainties and actual results for fiscal year 201 and beyond
could differ materially from the company's current expectations.
Forward-looking statements are identified by such words as
"anticipates", "projects", "expects", "planned", "intends" and
"believes" "estimate" "targets" and other similar expressions that
indicate trends and future events. It is understood that investment
entails risk on the part of the investor and could result in the
loss of some or all of his or her investment.
Acology Inc. and D&C Distributors are located in their new
production and distribution facility at 1630 Commerce St. Corona,
California, 92880. Acology trades on the OTC under the call letters
ACOL. The company's emails are www.theMedtainer.com for the medical and
recreational MJ industry and www.Acologyinc.com for the hospice and
palliative care industry. Please send inquiries to info@acologyinc.com or call (844) ACOLOGY
(844-226-5649) Ext. 3